Frontlight ResearchEarly access
Trial site
Angel City Research, Inc.
- 6running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Peripheral artery disease3 trials
- Type 2 diabetes3 trials
- Diabetic neuropathy2 trials
- Chronic kidney disease1 trial
- Diabetic eye disease1 trial
- Diabetic foot ulcer1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 37 trials
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Completed2 trials
- Not yet recruiting1 trial
- Suspended1 trial
- Lead sponsor
- Novo Nordisk A/S3 trials
- Vertex Pharmaceuticals Incorporated2 trials
- Eli Lilly and Company1 trial
- Fractyl Health Inc.1 trial
- Piomic Medical1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Peripheral artery disease2 recruiting
- Diabetic foot ulcer1 recruiting
- Diabetic neuropathy1 recruiting
Closed trials
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026